Want to stay in touch with the latest updates from The New Indian Express - Health? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.
Reading your RSS feed has never been easier!
Website title: The New Indian Express - Health
Is this your feed? Claim it!
The annual pollution problem in North India is no longer just an environmental inconvenience; but a full-scale biological stressor. And the data continues to be sobering. The Air Quality Life Index (AQLI) projected an 8.2-year reduction in life expectancy for Delhi by 2025. It is not merely a statistic, but a reflection of chronic systemic inflammation, particulate-induced ox...
NEW DELHI: There is no scientific evidence linking COVID-19 vaccination to sudden deaths among young adults, a latest AIIMS-ICMR study has said.
The study found that most sudden deaths in India among both the young and old is due to cardiovascular diseases.
Also, smoking and alcohol intake was equally prevalent in those who died young and at old age.
The yea...
Schwarzkopf Professional Bonacure Frizz Away Shampoo and Treatment promise sleeker, more manageable hair, and after several weeks of use. The shampoo clearly emerges as the standout. It cleans effectively without stripping moisture, leaving the scalp fresh and the strands noticeably smoother even after the first few washes. Unlike many anti-frizz formulas that rely on heavy s...
When 52-year-old Harpreet Kaur logged into her favourite beauty platforms this season, she was ready for slashed prices and impulse indulgence—but not for the word serum greeting her from every product description. Body lotions, cleansers, foundations, powders—everything now promised skincare benefits. For a woman with sensitive skin, it felt less like innovation and more lik...
CHENNAI: Novo Nordisk has introduced Ozempic, its once-weekly injectable semaglutide, to the Indian market on Friday. Designed as an adjunct to diet and exercise for adults with uncontrolled type 2 diabetes, the drug marks an expansion of modern GLP-1–based therapy in a country that now carries one of the world’s heaviest burdens of diabetes and obesity.
India is home t...
